Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management
Szweda, Bertrand Friguet, Age-Dependent Declines in Proteasome Activity in the Heart, Archives of Biochemistry and Biophysics, Volume 397, Issue 2, 2002, Pages 298-304, ISSN 0003-9861, Murtaza G, Khan AK, Rashid R, Muneer S, Hasan SMF, Chen J
The underlying issues of insufficient bile production and thick or insufficient bile flow are likely still present
Tirzepatide has the most extensive published literature, with FDA approval, multiple completed Phase 3 trial programs (SURMOUNT, SURPASS), and extensive real-world evidence
It's rarely asked for, but it takes minutes to prepare and can smooth things over if anything gets flagged